The validation of expression levels based on single-cell sequencing datasets also showed that HES4 was significantly expressed in a variety of tumor-infiltrating immune cells (such as dendritic cells, monocytes, NK cells, macrophages, and neutrophils) and stromal cells (fibroblasts, smooth muscle cells, and endothelial cells). Here, HES4 is linked to neoplasm.